Cited by 36Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment ResearchNeurological diseases and metabolism

The evolution of parkinsonism in primary progressive apraxia of speech: a 6-year longitudinal study

Open access
Seckin, Zeynep Idil, Duffy, Joseph R., Strand, Edythe A., Clark, Heather M., Utianski, Rene L., Machulda, Mary M., Botha, Hugo, Ali, Farwa +4 more·2020·Parkinsonism & Related Disorders

Abstract

Introduction Primary progressive apraxia of speech (PPAOS) is a neurodegenerative syndrome in which patients present with an isolated motor speech disorder. Some PPAOS patients develop parkinsonism and other features of progressive supranuclear palsy (PSP) and/or corticobasal syndrome (CBS) over time. We aimed to assess the evolution of parkinsonian characteristics in PPAOS patients who had been followed yearly for at least six years.Methods From a large cohort of 46 PPAOS patients, eight were followed yearly for > 6-years in multiple NIH-funded grants. Parkinsonian and other features, including bradykinesia, tremor, rigidity, postural instability, apraxia, ocular motor function and cognition were assessed at each visit, and research criteria applied for PSP and CBS diagnosis. Neurological, speech-language test scores, and [18 F]fluorodeoxyglucose PET (FDG-PET) and MRI midbrain volumes were assessed.Results A Parkinson's plus syndrome developed in all eight patients (100%). Bradykinesia was the earliest feature, followed by rigidity and postural instability. Tremor was not a significant feature. Parkinsonism, limb apraxia and ocular motor impairment tended to develop four-to-five years after onset with some patients having slight asymmetric parkinsonism. Six patients (75%) met research criteria for probable PSP, although only one for PSP-Richardson's syndrome; three patients met criteria for possible CBS. Slightly asymmetric, left-sided, hypometabolism was observed on FDG-PET, not matching asymmetry of Parkinsonism. Midbrain hypometabolism was absent-minimal. Three patients had progressive midbrain volumes in the PSP-Richardson's syndrome range.Conclusions A Parkinson's plus syndrome may inevitably develop in PPAOS supporting PPAOS as an early presentation of a Parkinson's plus disorder.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.parkreldis.2020.09.039

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [13]Yorkston KM, Strand E, Miller R, Hillel A & Smith K, Speech deterioration in amyotrophic lateral sclerosis: Implications for the timing of intervention, Journal of Medical Speech-Language Pathology 1 (1993) 35– 46.

Cited by

Sorted by citations

Authors
Seckin, Z. I., Duffy, J. R., Strand, E. A., Clark, H. M., Utianski, R. L., Machulda, M. M., Botha, H., Ali, F., Thu Pham, N. T., Lowe, V. J., Whitwell, J. L., & Josephs, K. A.
Affiliations
Mayo Clinic (US)
Corresponding author
Josephs, Keith A.
Venue
Parkinsonism & Related Disorders
Publisher
Elsevier BV
Published
2020-12
Volume
81
Pages
34-40
ISSN
1353-8020 (ISSN-L)
OpenAlex
W3092380486
Cited by
36
References
30
Citations by year
2026: 1 · 2025: 8 · 2024: 8 · 2023: 7 · 2022: 2 · 2021: 8 · 2020: 2
FWCI
2.06
Type
journal article
Language
en
Open access
Locations
  • Parkinsonism & Related Disorders (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institutes of Health
Topics
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
Keywords
primary progressive apraxia of speech, parkinsonism
MeSH terms
Aged, Apraxias, Brain, Postural Balance, Female, Humans, Language Tests, Longitudinal Studies, Magnetic Resonance Imaging, Male, Middle Aged, Muscle Rigidity, Speech Disorders, Supranuclear Palsy, Progressive, Tremor, Cohort Studies, Hypokinesia, Radiopharmaceuticals, Fluorodeoxyglucose F18, Parkinsonian Disorders, Positron-Emission Tomography

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review